Testing multiple dose combinations in clinical trials.
Ontology highlight
ABSTRACT: Drug combination trials are often motivated by the fact that individual drugs target the same disease but via different routes. A combination of such drugs may then have an overall better effect than the individual treatments which has to be verified by clinical trials. Several statistical methods have been explored that discuss the problem of comparing a fixed-dose combination therapy to each of its components. But an extension of these approaches to multiple dose combinations can be difficult and is not yet fully investigated. In this paper, we propose two approaches by which one can provide confirmatory assurance with familywise error rate control, that the combination of two drugs at differing doses is more effective than either component doses alone. These approaches involve multiple
SUBMITTER: Saha S
PROVIDER: S-EPMC7309363 | biostudies-literature | 2020 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA